[Current views on anticoagulant and fibrinolytic treatment in coronary arterial disease].
D000284:Administration, Oral; D000925:Anticoagulants / Q000008:administration & dosage / Q000627:therapeutic use*; D003327:Coronary Disease / Q000188:drug therapy* / Q000201:enzymology; D005341:Fibrinolysin / Q000378:metabolism; D005343:Fibrinolytic Agents / Q000627:therapeutic use*; D006493:Heparin / Q000627:therapeutic use; D006801:Humans; D007275:Injections, Intravenous; D009203:Myocardial Infarction / Q000188:drug therapy; D009336:Necrosis / Q000517:prevention & control; D013997:Time Factors
D000925:Anticoagulants; D005343:Fibrinolytic Agents; D006493:Heparin; D005341:Fibrinolysin
Współczesne poglady na leczenie przeciwkrzepliwe i fibrynolityczne w przebiegu choroby wieńcowej.